ClinicalTrials.gg

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Daewon Pharmaceutical Co., Ltd. clinical trials

Its pipeline, or its studies — you choose. Free with an account during the beta.

The registry lists 49 studies whose lead sponsor is Daewon Pharmaceutical Co., Ltd. 7 are recruiting or about to start. Per ClinicalTrials.gov, last updated Nov 12, 2026.

Our grouping of 1 registry name, not the registry’s. See them and correct one ↓

Compare Daewon Pharmaceutical with Yuhan and AstraZeneca →

Pipeline: 9 programs

Each counted once: 9 with a study Daewon Pharmaceutical Co., Ltd. leads registered in the last two years.

  • Phase 1
  • Phase 2
  • Phase 3

The 5 phase-3 programs — sign in to see them, free: with every program, filter by condition or phase and sort by first study or primary completion.

“Registry” is the highest phase of Daewon Pharmaceutical Co., Ltd.’s own registered studies; Daewon Pharmaceutical Co., Ltd.’s own pipeline document is not read yet. “Primary completion” is the earliest date still ahead among its live studies when the main measure’s data collection ends, as the registry states it (most are estimates); results come later, if they are announced. Programs are read from ClinicalTrials.gov, joined across names by rules and decisions each recorded with its evidence.

What it is testing

The drugs Daewon Pharmaceutical Co., Ltd.’s studies test, most open studies first — 10 drugs with a page of their own. Each count opens the studies in search.

Open now Not open: under way, finished or stopped

Coming up

1 of Daewon Pharmaceutical Co., Ltd.’s studies under way reach primary completion within a year. The dates are the sponsor’s own estimates, which often move.

Phase 3 Other phases

  1. N’26
  2. 1D
  3. J’27
  4. F
  5. M
  6. A
  7. M
  8. J
  9. J
  10. A
  11. S
  12. O
  13. N

The study

Add it to your calendar (.ics) → With an account.

What changed recently

From the registry's own updates since Oct 19, 2026.

All 49 at a glance

Where each study is in its life, its phase and its countries. Each count opens them in search.

  • Open now714%Not yet recruiting 4 · Recruiting 2 · Enrolling by invitation 1
  • Completed3571%
  • Status unknown or other714%

Phase

  • Phase 320
  • Phase 120
  • Phase 44
  • Phase 24

Where

  • Korea, Republic of34

Over the years

  1. 10
  2. 11
  3. 12
  4. 13
  5. 514
  6. 15
  7. 16
  8. 17
  9. 18
  10. 19
  11. 20
  12. 21
  13. 22
  14. 23
  15. 24
  16. 25
  17. 426

By the year each study started. 2026 so far in the lighter column.

Registry sponsor names on this page

Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.

Tell us about a missing company
No account needed. Please leave out personal details.

Each name exactly as ClinicalTrials.gov lists it, and how it relates to Daewon Pharmaceutical Co., Ltd.

  • Daewon Pharmaceutical Co., Ltd.
    Same company
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    49 studies

Studies

Recruiting first, then most recently updated. Showing 49 of 49.